Homepage

Biosimilars are an opportunity to help reduce the burden of rising treatment costs.

Diversity drives innovation, which in turn drives change and progress.

At Sandoz our work is focused on improving access to medicines, access to medical information and access ...

Sandoz announced a commitment of $10 million USD in medicines to Americares.

Explore Novartis

Featured / Jan 27

Coronavirus disease (COVID-19) update

As Novartis continues to closely monitor the coronavirus situation, our primary concern is the health and safety of our associates and patients globally. We will continue to deliver our medicines to patients around the world and we do not anticipate supply chain disruption at this time.

See our product listing, including: NDCs, Size, Dosage Forms and more.